Mangoceuticals Inc (MGRX) Shares Soar Above 1-Year High

TEAM

Mangoceuticals Inc (NASDAQ: MGRX)’s stock price has gone rise by 9.01 in comparison to its previous close of 0.24, however, the company has experienced a -1.19% decrease in its stock price over the last five trading days. InvestorPlace reported 2023-12-15 that Mangoceuticals (NASDAQ: MGRX ) stock is dropping on Friday after the men’s wellness products company launched a stock offering this morning. That stock offering has the company selling 5 million shares of MGRX stock.

Is It Worth Investing in Mangoceuticals Inc (NASDAQ: MGRX) Right Now?

Company’s 36-month beta value is 1.27.

The public float for MGRX is 13.57M, and currently, short sellers hold a 1.46% ratio of that floaft. The average trading volume of MGRX on May 02, 2024 was 812.85K shares.

MGRX’s Market Performance

The stock of Mangoceuticals Inc (MGRX) has seen a -1.19% decrease in the past week, with a 26.19% rise in the past month, and a -26.59% fall in the past quarter. The volatility ratio for the week is 13.21%, and the volatility levels for the past 30 days are at 13.25% for MGRX. The simple moving average for the past 20 days is 0.78% for MGRX’s stock, with a -56.71% simple moving average for the past 200 days.

MGRX Trading at 17.48% from the 50-Day Moving Average

After a stumble in the market that brought MGRX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -88.87% of loss for the given period.

Volatility was left at 13.25%, however, over the last 30 days, the volatility rate increased by 13.21%, as shares surge +23.31% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +17.78% upper at present.

During the last 5 trading sessions, MGRX fell by -1.19%, which changed the moving average for the period of 200-days by -83.54% in comparison to the 20-day moving average, which settled at $0.2655. In addition, Mangoceuticals Inc saw -4.30% in overturn over a single year, with a tendency to cut further losses.

Stock Fundamentals for MGRX

Current profitability levels for the company are sitting at:

  • -12.6 for the present operating margin
  • 0.59 for the gross margin

The net margin for Mangoceuticals Inc stands at -12.59. The total capital return value is set at -10.98. Equity return is now at value -1326.69, with -896.99 for asset returns.

Based on Mangoceuticals Inc (MGRX), the company’s capital structure generated 0.14 points at debt to capital in total, while cash flow to debt ratio is standing at -54.38. The debt to equity ratio resting at 0.17. The interest coverage ratio of the stock is -5238.01.

Currently, EBITDA for the company is -9.19 million with net debt to EBITDA at 0.07. When we switch over and look at the enterprise to sales, we see a ratio of 7.72. The receivables turnover for the company is 6283477024505856.0for trailing twelve months and the total asset turnover is 0.7. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.88.

Conclusion

In a nutshell, Mangoceuticals Inc (MGRX) has experienced a bad performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.

Most Popular

Related Posts